KemPharm Competitors and Similar CompaniesClear all
F-star Biotechnology's competitors and similar companies include Actinium Pharmaceuticals and Juno Therapeutics.
 F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |  Actinium Pharmaceuticals Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | |
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 2013 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations New York, US HQ | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 39 | Employees 2517% decrease | Employees 1091% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) $90k (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income (£2.6m) (FY, 2018) | Net income N/A | Net income ($437.1m) (FY, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 57.3m | Total funding raised $ 7m | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Actinium Pharmaceuticals
HQ
New York, US
Employees
25↓ 17% decrease
Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.
View companyJuno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company